THE AUSTRIAN VACCINATION PARADOX: TICK-BORNE ENCEPHALITIS VACCINATION VERSUS INFLUENZA VACCINATION
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
26615654
DOI
10.21101/cejph.a4169
Knihovny.cz E-resources
- MeSH
- Influenza, Human epidemiology prevention & control MeSH
- Encephalitis, Tick-Borne epidemiology prevention & control MeSH
- Humans MeSH
- Patient Acceptance of Health Care MeSH
- Health Promotion organization & administration MeSH
- Social Marketing MeSH
- Influenza Vaccines administration & dosage MeSH
- Viral Vaccines administration & dosage MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Austria epidemiology MeSH
- Names of Substances
- Influenza Vaccines MeSH
- Viral Vaccines MeSH
This paper describes a paradoxical situation in Austria. The vaccination rate against tick-borne encephalitis (TBE) in the general population is 82%, which is the highest worldwide, whereas the vaccination rate against influenza is about 8% and is among the lowest worldwide. A high awareness of TBE among the Austrian population achieved by an annual social marketing programme and the wide use of effective and well-tolerated vaccines have led to a successful containment of that disease. The vaccination coverage increased from 6% in 1980 to 82% in 2013 and exceeds 90% in some high-risk areas. This has led to a steady decline in the number of TBE cases from several hundred cases to 50 to 100 cases per year. The situation in regard to influenza vaccination is the opposite. Although Austria has issued one of the most extensive recommendations for influenza vaccination worldwide, the vaccination rate of the general population is extremely low. The possible reasons for the failure in the implementation of recommendations are ignorance, lack of social marketing and the predominance of a distinct discordance within the health system in general, and the Austrian medical fraternity in particular.
References provided by Crossref.org
Spatiotemporal spread of tick-borne encephalitis in the EU/EEA, 2012 to 2020